Bortezomib plus melphalan and prednisone for multiple myeloma

N Engl J Med. 2008 Dec 11;359(24):2613; author reply 2613-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage
  • Boronic Acids / adverse effects*
  • Bortezomib
  • Humans
  • Melphalan / administration & dosage
  • Melphalan / adverse effects
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Pyrazines / administration & dosage
  • Pyrazines / adverse effects*
  • Survival Rate

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Melphalan
  • Prednisone